Feeder-Free Pluripotent Cell Differentiation via Defined Media
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating pluripotent stem cells into hematopoietic progenitor cells face challenges due to the use of animal-derived products like serum and mouse feeder cells, leading to variability and regulatory issues, and there is a need for methods that can achieve this differentiation without interspecies exposure.
Innovation Solution
A method involving sequential exposure of pluripotent cells to defined media compositions, including specific growth factors like BMP4, VEGF, IL-3, Flt3 ligand, and GMCSF, under controlled conditions, without the need for animal products, to promote the differentiation into hematopoietic precursor cells or endothelial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If mouse feeder cells are used to culture pluripotent stem cells, then cell expansion and maintenance are improved, but interspecies exposure and transformation risks increase
Solution Approach 1:
The patent removes mouse feeder cells from the culture system entirely, extracting the harmful interspecies exposure element while maintaining pluripotent stem cell expansion through feeder-free conditions with defined media compositions
Solution Approach 2:
The patent introduces defined media compositions containing specific growth factors (bFGF, TGF-beta, etc.) as intermediaries to replace the functional role of mouse feeder cells, enabling human pluripotent stem cell maintenance without interspecies contact
2Productivity
If serum is used in differentiation medium, then cell differentiation is supported, but batch variability and regulatory issues increase
Solution Approach 1:
The patent changes the composition parameters of the culture medium from undefined serum-based media to defined media with specific growth factors, eliminating batch variability while maintaining differentiation efficiency
Solution Approach 2:
The patent creates a synthetic copy of serum functionality using recombinant growth factors (bFGF, TGF-beta, VEGF, etc.) that replicate the biological activities needed for differentiation without the variability of animal serum
3Object-affected harmful factors
If defined media without animal products are used, then clinical concerns are reduced, but differentiation efficiency may decrease
Solution Approach 1:
The patent creates a composite defined media system combining multiple growth factors (bFGF, TGF-beta, VEGF, IL-3, Flt3 ligand, GM-CSF) that work synergistically to achieve efficient differentiation without animal products
Solution Approach 2:
The patent segments the differentiation process into sequential stages with specific media compositions at each stage, optimizing differentiation efficiency at each phase while maintaining freedom from animal products
Data Source
AI summary
Provided herein are methods for the in vitro maintenance, expansion, culture, and/or differentiation of pluripotent cells, such as human embryonic stem cells (hESC) or induced pluripotent cells (iPSC), into hematopoietic precursor cells or endothelial cells. The pluripotent cells may be maintained and differentiated under defined conditions; thus, the use of mouse feeder cells or serum is not required in certain embodiments for the differentiation of the pluripotent cells into hematopoietic precursor cells or endothelial cells. The resulting hematopoietic precursor cells may be further differentiated into various myeloid or lymphoid lineages.